Anti-inflammatory activity of Cymbopogon citratus leaves infusion via proteasome and nuclear factor-κB pathway inhibition: contribution of chlorogenic acid by Francisco, Vera et al.
 Anti-inflammatory activity of Cymbopogon citratus leaves infusion via 
proteasome and nuclear factor-B pathway inhibition: contribution of 
chlorogenic acid 
Vera Francisco a, b, Gustavo Costa b, c, Artur Figueirinha b, d, Carla Marques e, Paulo Pereira e, 
Bruno Miguel Neves f, Maria Celeste Lopes a, c, Carmen García-Rodríguez g, Maria Teresa Cruz 
a, c, Maria Teresa Batista b, c, * 
a Center for Neurosciences and Cell Biology, University of Coimbra, Azinhaga de Santa Comba, 
3004-517 Coimbra, Portugal 
b Center for Pharmaceutical Studies, Faculty of Pharmacy, University of Coimbra, Pólo das 
Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal 
c Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa 
Comba, 3000-548 Coimbra, Portugal 
d Department of Environment, Polytechnic Institute of Viseu, Campus Politécnico de Repeses, 
3504-510 Viseu, Portugal 
e Center of Ophthalmology and Vision Sciences, Institute for Biomedical Research in Light and 
Image, Faculty of Medicine, University of Coimbra, Azinhaga de Santa Comba, 3000-548 
Coimbra, Portugal 
f Mass Spectrometry Center, Chemistry Department, University of Aveiro, 3810-193 Aveiro, 
Portugal 
g Instituto de Biología y Genética Molecular, Universidad de Valladolid – CSIC, C/ Sanz y Forés 
3, 47003-Valladolid, Spain 
*Phone: +351 239488497; Fax: +351 239827126; E-mail: mtpmb@ff.uc.pt 
 
 
  
Abstract 
Ethnopharmacological relevance: Cymbopogon citratus (DC) Stapf leaves infusion is used in 
traditional medicine for the treatment of inflammatory conditions, however little is known about 
their bio-active compounds.  
Aim of the study: Investigate the compounds responsible for anti-inflammatory potential of 
Cymbopogon citratus (Cy) on cytokines production induced by lipopolysaccharide in human and 
mouse macrophages, and the action mechanisms involved. 
Materials and methods: An essential oil-free infusion of Cy was prepared and polyphenol-rich 
fractions (PFs) were obtained from it by column chromatography. Chlorogenic acid was 
identified, by HPLC/PDA/ESI-MSn. The expression of cytokines, namely TNF- and CCL5, was 
analyzed by real-time RT-PCR, on lipopolysaccharide-stimulated human macrophages. 
Activation of nuclear factor-B, a master regulator of inflammation, was investigated by Western 
blot and gene reporter assay. Proteasome activity was assessed using a fluorogenic peptide. 
Results: Cymbopogon citratus extract and its polyphenols inhibited the cytokine production on 
human macrophages. This supports the anti-inflammatory activity of Cy polyphenols in 
physiologically relevant cells. Concerning the effect on the activation of nuclear factor (NF)-B 
pathway, the results pointed to an inhibition of LPS-induced NF-B activation by Cy and PFs. 
Chlorogenic acid was identified, by HPLC/PDA/ESI-MSn, as the main phenolic acid of the Cy 
infusion, and it demonstrated to be, at least in part, responsible by that effect. Additionally, it 
was verified for the first time, that Cy and PFs inhibited the proteasome activity, a complex that 
controls NF-B activation, having CGA a strong contribution.  
Conclusions: The results evidenced, for the first time, the anti-inflammatory properties of 
Cymbopogon citratus through proteasome inhibition and, consequently NF-B pathway and 
cytokine expression. Additionally, Cy polyphenols, in particular chlorogenic acid, were 
highlighted as bio-active compounds. 
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1. Introduction 
Inflammation is pointed out in preclinical studies as a major mechanism in the 
pathogenesis of chronic diseases, namely diabetes, hypertension and cancer (Liu and Zeng, 
2012; Osborn and Olefsky, 2012; Price et al., 2012). During an inflammatory response, 
macrophages release several inflammatory mediators, such as cytokines, which expression is 
regulated by different intracellular signaling pathways (O’Neill, 2006). Inflammatory stimuli can 
activate the nuclear factor (NF)-B by signaling events that lead to the phosphorylation of the 
inhibitory protein B (IB) by the IB kinase (IKK), with subsequent ubiquitination and 
degradation by ubiquitin-proteasome system (Vitiello et al., 2012), a pivotal complex in 
inflammation and cancer development (DiDonato et al., 2012). The IB degradation unmasks 
the nuclear localization motif of NF-B, allowing its rapid translocation to the nucleus and the 
transcription of many inflammatory mediators, like tumor necrosis factor (TNF)- and chemokine 
(C-C motif) ligand 5 (CCL5). Once released by the cell, TNF- elicits several physiological 
effects of inflammation (Kopf et al., 2010) and CCL5 has significant chemotactic activity for 
inflammatory cells (Schober, 2008). The NF-B activation also induces the transcription of 
inducible nitric oxide synthase (iNOS), leading to the production of nitric oxide (NO), that is a 
pro-inflammatory mediator. The overproduction of NO contributes to the pathogenesis of septic 
shock and inflammatory diseases (Zamora et al., 2000; Guzik et al., 2003). Since the 
overproduction of these pro-inflammatory mediators raises and maintains inflammation, 
compounds targeting its expression and production through NF-B and proteasome pathways 
are good candidates for attenuating inflammation. 
Cymbopogon citratus (DC) Stapf (Cy), Poaceae-Gramineae, commonly known as 
lemongrass, is a spontaneous perennial graminoid, largely distributed in tropical and subtropical 
countries. In traditional medicine, aqueous extracts of dried leaves are used for the treatment of 
several inflammation-based pathologies (Shah et al., 2011). Accordingly, we previously 
demonstrated that Cy and its polyphenols inhibited nitric oxide (NO) production, in dendritic 
cells and mouse macrophages, through modulation of p38 mitogen-activated protein kinase 
(MAPK), c-Jun N-terminal kinase (JNK) 1/2 and NF-B signaling pathways (Figueirinha et al., 
2010; Francisco et al., 2011), which evidences the potential of Cy as source of compounds with 
anti-inflammatory properties. 
The present paper aimed to investigate the effect of Cy, as well its polyphenols, on the 
lipopolysaccharide (LPS)-induced cytokines production, in human macrophages, and the 
involvement of NF-B and proteasome in the anti-inflammatory profile of Cymbopogon citratus. 
Considering the potential of phenolic acids to the anti-inflammatory properties of Cy, 
HPLC/PDA/ESI-MSn was performed in order to identify the main phenolic acid present, its 
biological activity being subsequently assessed on the pure compound. 
 
2. Materials and Methods 
2.1. Plant material, infusion preparation and extract fractionation 
Dry leaves of Cymbopogon citratus Stapf (Cy) were purchased from ERVITAL® (Mezio, 
Castro Daire, Portugal). The plant was cultivated in the region of Mezio, Castro D´Aire 
(Portugal). A voucher specimen was deposited in the Herbarium of Aromatic and Medicinal 
Plants of the Faculty of Pharmacy - University of Coimbra (A. Figueirinha 0109). The identity of 
the plant was confirmed by J. Paiva (Botany Department, University of Coimbra, Portugal). An 
lipid- and essential oil-free infusion was prepared and fractionated by column chromatography 
as previously described (Figueirinha et al., 2008). Briefly, the extract was treated with water and 
fractionated on a reverse phase semipreparative column Lichroprep® RP-18 (310 x 25 mm, 
particle sizes 40-63 m), Merck (Darmstadt, Germany), eluted with water giving fraction F1 and 
with aqueous methanol solutions (fractions F2-F7). Dry residue of F7 was recovered in 50% 
aqueous ethanol and fractionated by gel chromatography on a Sephadex® LH-20 (Sigma-
Aldrich – Amersham, Sweden) column (85 x 2.5 cm) using ethanol as mobile phase. All the 
fractionation process was monitored by high-performance liquid chromatography (HPLC) and 
thin layer chromatography (TLC) for polyphenols, providing three major fractions: tannin-rich 
fraction (TF; yield of 3.5% (w/w) of Cy extract) corresponding to F6, flavonoid-rich fraction (FF; 
yield of 4.4% (w/w) of Cy extract) corresponding to sub-fraction F7a, and phenolic acid-rich 
fraction (PAF; yield of 23.8% (w/w) of Cy extract) corresponding to F2 and sub-fraction F7b, as 
described in Figueirinha et al. (2010). The Cy extract and the polyphenol-rich fractions were 
weighted in sterilized and humidity-controlled conditions, and then Cy extract solubilized in 
sterilized water and polyphenol-rich fractions in sterilized phosphate buffered saline. 
 
2.2. HPLC and mass spectrometry analyses 
Structural elucidation of chlorogenic acid (CGA) was carried out on a Surveyor liquid 
chromatograph equipped with a photodiode array (PDA) detector (Surveyor) and interfaced with 
a Finnigan LCQ Advantage Ion Max tandem mass spectrometer (Thermo Fisher Scientific, 
Waltham, MA, USA) equipped with an API-ES ionization chamber. Separation was performed 
on a Spherisorb ODS-2 column (150x2.1 mm i.d.; particle size, 3 m; Waters Corp., Milford, 
MA, USA) and a Spherisorb ODS-2 guard cartridge (10x4.6 mm i.d.; particle size, 5 m; Waters 
Corp., Milford, MA, USA) at 25ºC. A mobile phase constituted by 2% aqueous formic acid (v/v) 
(A) and methanol (B) was used with a discontinuous gradient of 5–15% B (0–10 minutes), 15–
25% B (10–15 minutes), 25–50% B (15–40 minutes), 50–80% B (40–50 minutes), followed by 
an isocratic elution (50–60 minutes), a gradient  80–100% B (60–65 min) and other isocratic 
elution for 5 minutes, at a ow rate of 200 L.min-1. The rst detection was done with a PDA 
detector in a wavelength range 200–400 nm, followed by a second detection in the mass 
spectrometer. Mass analyses were obtained in the negative ion mode. The mass spectrometer 
was programmed to perform three consecutive scans: full mass (m/z 125–1500), MS2 of the 
most abundant ion in the full mass and MS3 of the most abundant ion in the MS2. Source 
voltage was 4.5 kV and the capillary voltage and temperature were -10 V and 250ºC, 
respectively. Nitrogen was used as sheath and auxiliary gas at 20 Finnigan arbitrary units. The 
normalized energy of collision was 45%, using helium as collision gas. Data treatment was 
carried out with XCALIBUR software (Thermo Scientific, Waltham, MA, USA). 
HPLC profiles of the Cy extract and PAF, as well the CGA quantification were performed in 
a chromatograph equipped with a PDA (Gilson Electronics SA, Villiers le Bel, France). The 
studies were carried out as previously (Figueirinha et al., 2008). Chromatographic proles were 
acquired in the wavelength range of 200–600 nm and recorded at 280 and 320 nm. Data 
treatment was carried out with Unipoint®, version 2.10 software (Gilson, Middleton, WI, USA).  
A standard stock solution of chlorogenic acid (HPLC-grade purity from Sigma) was used for 
the quantification. Calibration curve was obtained by diluting stock standard in methanol to yield 
0.3-10 g/mL. The absorbance was recorded at 320 nm and the linearity between the response 
and concentration was evaluated by regression analysis. The samples were analyzed in 
triplicate. 
 
2.3. Cell culture and chemical treatment 
Human monocytes were isolated from buffy coats of healthy volunteer donors by 
centrifugation into Ficoll cushions and adherence to plastic dishes. Adhered monocytes were 
cultured in RPMI (Lonza, Basel, Switzerland) supplemented with 2 mM L-glutamine, 40 g/mL 
of gentamicin (Lonza, Basel, Switzerland) and 5% (v/v) heat-inactivated human serum for 2 
weeks in the absence of exogenous cytokine mixtures in order to differentiate into 
macrophages. RAW 264.7 (ATCC number: TIB-71) was cultured in Iscove´s Modified 
Dulbecco’s Media (Sigma–Aldrich Química, Madrid, Spain) supplemented with 10% (v/v) non-
inactivated fetal bovine serum (Gibco, Paisley, UK), 100 U/mL penicillin and 100 g/mL 
streptomycin (both from Sigma–Aldrich Química, Madrid, Spain). The cells were cultured at 
37°C in a humified atmosphere of 95% air and 5% CO2. The investigation conforms to the 
principles outlined in the Declaration of Helsinki. 
For the experiments, cells were maintained in culture medium (control) or pre-incubated 
with 1.115 mg/mL Cy, 530 g/mL PAF, 97.5 g/mL FF, 78 g/mL TF, or indicated 
concentrations of CGA (Sigma Chemical Co., St. Louis, MO, USA) for 1 h. Then, 1 μg/mL 
lipopolysaccharide (LPS) from Escherichia coli (serotype 026:B6) (Sigma Chemical Co., St. 
Louis, MO, USA) was added for the indicated period of time. The Cy concentration used was 
based in previous studies (Figueirinha et al., 2010; Francisco et al., 2011) while the PFs 
concentration was based on their ratios in the Cy extract after fractionation: PAF (23.8%), FF 
(4.4%) and TF (3.5%). The CGA concentrations were selected based on its concentration in 
PAF (3.33%) and PAF ratio in the Cy extract (23.8%). 
 
2.4. RNA extraction and real-time RT-PCR 
Human macrophages were pre-incubated with Cy extract or PFs for 1h and then, with LPS 
for 8h. Total RNA was isolated from cells with Trizol® reagent (Invitrogen, Barcelona, Spain). 
The concentration and purity of the RNA samples were evaluated by spectrophotometry using 
NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies Inc.). RNA reverse 
transcription was performed using iScriptTM select cDNA synthesis kit (BioRad, Hercules, CA, 
USA), accordingly to manufactory instructions, on C1000TM Thermal Cycler (BioRad, Hercules, 
CA, USA). 
The resulting cDNA of the housekeeping gene glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), used as endogenous control, TNF- and CCL5 were amplified by 
real-time RT-PCR, using the SYBR-Green (BioRad, Hercules, CA, USA) assay to monitor the 
amplification reactions on a Bio-Rad My Cycler iQ5. For that, specific primers (MWG Biotech, 
Ebersberg, Germany) were designed using Beacon Designer® Software v7.2 (Primier Biosoft 
International) (Table 1). Gene expression changes were analyzed using the built-in iQ5Optical 
system software v2, with the Pfaffl method (Pfaffl, 2001). Gene expression was expressed as 
relative fold changes compared to LPS and normalized to GAPDH. 
 
2.5. Western blot 
Total cell lysates were prepared using the RIPA buffer [50 mM Tris–HCl (pH 8.0), 1% 
Nonidet P-40, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS and 2 mM EDTA] freshly 
supplemented with 1 mM DTT, protease and phosphatase inhibitor cocktails (Roche, Basel, 
Switzerland). Cytoplasmic and nuclear extracts were obtained by a commercial nuclear extract 
kit (Active Motif, Rixensart, Belgium), accordingly to manufactory instructions. Protein 
concentration of cell lysates was determined by the bicinchoninic acid protein assay. Cell 
lysates were denaturated at 95 ºC, for 10 min, in sample buffer [0.125 mM Tris (pH 6.8), 2% 
(w/v) SDS, 100 mM DTT, 10% glycerol and bromophenol blue]. 
Cell lysates were subjected to SDS-polyacrylamide gel electrophoresis transferred to 
polyvinylidene fluoride membranes and specific antibodies (Cell Signaling Technologies, 
Danvers, MA, USA) against phospho-IB, total IB and NF-B p65 were used. The immune 
complexes were detected using the enhanced chemifluorescence reagent (GE Healthcare, 
Chalfont St. Giles, UK) on the Storm 860 (GE Healthcare) and analyzed by software 
ImageQuant TL®. To demonstrate equivalent protein loading, membranes were stripped and 
reprobed with antibodies against actin (Millipore, Bedford, MA, USA) or lamin (Calbiochem, 
Darmstadt, Germany). 
 
2.6. Dual-Luciferase assay 
RAW 264.7 were transiently transfected with NF-B-dependent firefly luciferase-expressing 
plasmid using LipofectamineTM LTX and Plus Reagent (Invitrogen, Paisley, UK). After chemical 
treatment and incubation with LPS for 8h, the luciferase activity was measured using the Dual 
Luciferase® reporter assay system (Promega, Madison, WI, USA), accordingly to 
manufacturer’s instructions, in the MicroLumat Plus LB96V Luminometer (EG&G Berthold, Bad 
Wildbad, Germany). Injectors were programmed to dispense 50 μL of LAR II and Stop & Glo® 
reagent and measure was performed using 2-second delay and a 10-second read time. 
 
2.7. Chymotrypsin-like activity of proteasome 
Cytosolic extracts were prepared using lysis buffer [50 mM Tris-HCl (pH 7.6) with 1 mM 
DTT] followed by sonication and centrifugation to remove cell debris. Fluorogenic peptide Suc-
LLVY-AMC (Biomol International, Plymouth Meeting, PA, USA) at 70 μM was added to 20 μg 
protein of cytosolic extracts. Fluorescence was measured at 37ºC in Biotek Synergy HT 
spectrophotometer (Biotek, Winooski, VT, USA), using excitation wavelength of 360 nm and 
emission wavelength of 460 nm. The Gen 5 software (Biotek, Winooski, VT, USA) was used to 
monitor the results. 
 
2.8. Nitric oxide production 
The production of NO was measured by the accumulation of nitrites in the culture 
supernatants, using a colorimetric reaction with the Griess reagent, as previously described 
(Francisco et al., 2011). 
 
2.9. Statistical analysis 
Two-sided unpaired t-test was used to compare LPS-stimulated cells with control, while 
One-way ANOVA followed by Dunnett’s test was applied to compare the effect of different 
treatments on LPS-stimulated cells. GraphPad Prism, version 5.02 (GraphPad Software, San 
Diego, CA, USA) was used to perform the statistical analysis. The significance level was 
#p<0.05, ##p<0.01 and ###p<0.001, when compared to control and *p<0.05, **p<0.01 and 
***p<0.001, when compared to LPS. 
 
3. Results 
 
3.1. Chlorogenic acid identification and quantification 
The main phenolic acid from Cy was separated and identified by HPLC/PDA/ESI-MSn. UV 
spectrum showed the typical maxima of a caffeic acid derivative: 251, 298sh and 326 nm, mass 
spectrum at MS1 being characterized for the presence of two main signals: the base peak at m/z 
353 (100%) and a slightly less abundant peak at m/z 707 (79%) (Fig. 1A). The ion at m/z 353 is 
consistent with the presence of a compound with a C16H18O9 formula, characteristic of a 
caffeoylquinic-type phenolic acid (Fang et al., 2002). As in other quinic acid esters, the 
caffeoylquinic acids in the negative ion mode originate ions by two competing pathways (Fig. 
1B); pathway I, with the ions Q2 (m/z 173), C1 (m/z 179) and C2 (m/z 135) and pathway II, with 
the characteristic presence of the fragment Q1 (m/z 191) (Bravo et al., 2007). For this 
compound, the presence of fragments at m/z 191 (100%) (MS2) and m/z 173 (100%) (MS3) 
seems to confirm the presence of a caffeoylquinic acid. The relative abundance of fragments 
referred can be used for the identification of the chlorogenic acids: cryptochlorogenic, 
chlorogenic and neochlorogenic acids (Fang et al., 2002). The fragmentation of 
cryptochlorogenic acid follows pathway I, presenting the ion Q2 at m/z 173 as the base peak of 
the MS2 spectrum, while chlorogenic and neochlorogenic acids follow pathway II, with a base 
peak at m/z 191, corresponding to fragment Q1. In case of chlorogenic acid (CGA), the pseudo 
molecular ion originates a fragment Q1 at m/z 179 with a relative abundance lower (about 5%) 
than that of the neochlorogenic acid (20-60%). For the main phenolic acid of Cy we verified that 
the fragment at m/z 179 presented a relative abundance of 5% (Fig. 1A), suggesting the 
presence of CGA as the most probable structure. The signal at m/z 707 was reported as a 
result of a dimeric adduct of the pseudo-molecular ion m/z 353, in the same analytical 
conditions (Bravo et al., 2007). 
Two main phenolic acids, the CGA and a p-coumaric acid derivative, with retention times of 
19.95 and 25.33 min, respectively, were detected in a phenolic acid-rich fraction (PAF) prepared 
from Cy extract, CGA being the most representative (Fig. 1C). The CGA quantification by 
HPLC-PDA system revealed that this phenolic acid represents 1.11% (w/w) of Cy extract and 
3.33% (w/w) of PAF. 
 
3.2. Pro-inflammatory cytokines expression 
Given the important role of cytokines production in inflammation, the expression of TNF- 
and CCL5 in LPS-stimulated human macrophages were evaluated by real-time RT-PCR (Fig. 
2A and 2B). The pre-treatment of cells with Cy extract decreased the LPS-induced TNF- 
mRNA levels by 64.89±5.04%. In addition, PFs reduced the LPS-induced TNF- expression, 
being phenolic acids and tannins as potent as Cy extract. Relatively to CCL5 expression, Cy 
extract inhibited LPS-induced CCL5 mRNA levels by 47.04±12.52. Cy polyphenols showed 
some inhibition of CCL5 expression, however it was not statistically significant. Taken together, 
data evidence the pharmacological importance of Cymbopogon citratus and its polyphenols 
through the inhibition of cytokines expression. 
 
3.3. NF-B activation 
The expression of pro-inflammatory cytokines is mainly regulated by NF-B pathway. So, 
the effect of Cy extract and its PFs on NF-B activation was assessed by western blot and 
reporter assays. The pre-treatment of human macrophages with Cy extract, maintained the 
LPS-induced IB phosphorylation (Fig. 2C) and blocked the degradation of IB (Fig. 2D), 
suggesting the inhibition of NF-B activation. Additionally, the inhibition of IB degradation by 
TF was verified, suggesting the TF contribution to the Cy inhibitory activity. 
Reinforcing these results, the same behavior was confirmed in murine macrophages. In 
fact, pre-treatment with Cy extract maintained the phosphorylation levels of IB (Fig. 3A) and 
the blockade of IB degradation induced by LPS (Fig. 3B). It was verified that none of the three 
fractions have a significant effect in LPS-induced IB phosphorylation, but PAF and FF 
inhibited the IB degradation (Fig. 3B). Interestingly, a standard of the main phenolic acid in Cy 
extract, the chlorogenic acid, maintained the phosphorylation levels of IB, such as the Cy 
extract. Immunodetection of p65 in cytosolic and nuclear extracts demonstrated the inhibition of 
p65 translocation to the nucleus by Cy extract (Figs. 3C and 3D), this result being consistent 
with a NF-B inhibition by Cy. Additionally, all the PFs inhibited the transcriptional activity of NF-
B (Fig. 3E), thus suggesting their contribution to the Cy extract anti-inflammatory potential by 
inhibition of NF-B activation. 
All together, the data demonstrate that Cy extract inhibited the NF-B activation in human 
and murine macrophages, being polyphenols partially responsible by this anti-inflammatory 
mechanism. 
 
3.4. Proteasome activity 
The ubiquitin-proteasome system has a central role in the regulation of NF-B as well other 
inflammatory signaling pathways (Shen et al., 2006). So, the chymotrypsin-like activity of 
proteasome was investigated. In LPS-activated murine macrophages, Cy extract significantly 
decreased the proteasome activity by 38±6.4% (Fig. 4), which is concordant with the blockade 
of IB degradation and maintenance of its phosphorylation status. Both phenolic acid- and 
tannin-rich fractions inhibited proteasome activity; However, only in particular, PAF decreased, 
with statistic significance, the proteasome activity by 24.5±9.8%, suggesting a specific effect 
strong contribution of Cy phenolic acids for this activity. Therefore, the effect of chlorogenic 
acid, the main phenolic acid present in Cy extract and PAF, was assessed. CGA (17.5 g/mL) 
inhibited the proteasome activity by 28.43±22.09% and, so, strongly contributes to the inhibition 
of proteasome by Cy in LPS-stimulated murine macrophages. This data also supports the anti-
inflammatory properties of Cy extract through inhibition of NF-B activation and, consequently, 
cytokines expression. 
 
3.5. Nitric oxide production 
Given the inhibitory activity of CGA on NF-B pathway and proteasome activity, its anti-
inflammatory properties were then evaluated through measurement of NO production by Griess 
assay, in murine macrophages. The inhibition of LPS-induced nitrite production by CGA is 
statistically significant at 140 g/mL (Fig. 5), which indicates that CGA inhibited proteasome 
activity at lower doses (17.5 g/mL) but a higher concentration is needed to inhibit the 
production of pro-inflammatory mediators, such as NO. None of the concentrations used 
affected the cell viability (data not shown). 
 
 
 
 
4. Discussion 
In this study, the anti-inflammatory action of a lipid- and essential oil-free extract from 
Cymbopogon citratus, in human macrophages, was proved. The results demonstrated that Cy 
extract inhibits cytokine expression through NF-B pathway and, for the first time, this inhibition 
through ubiquitin-proteasome system was referred. Moreover, data support a contribution of 
polyphenols for the anti-inflammatory activity of the Cy extract, pointing chlorogenic acid as a 
bioactive compound responsible for proteasome system inhibition. 
Cytokines have a central role in inflammation, driving the inflammatory response to 
protective immunity or to induction of immunopathology, with the clinical outcome partly 
determined by the balance between pro- and anti-inflammatory molecules. Here a decrease in 
LPS-induced TNF- and CCL5 expression by Cy extract, in human macrophages, was verified. 
TNF- is a cytokine that induces several pro-inflammatory effects (Kopf et al., 2010) and with an 
important role in linking inflammation and cancer (Liu and Zeng, 2012), while CCL5 is a 
chemokine that recruits leukocytes, including T-cells and monocytes (Schober, 2008). Since the 
deregulated production of these cytokines was associated with inflammatory and autoimmune 
diseases, the inhibition of both TNF- and CCL5 expression by Cy extract evidenced its anti-
inflammatory potential. 
Elucidating the bioactive compounds of Cy, the present data demonstrated that Cy 
polyphenols could account, at least partially, for the inhibition of TNF- expression. The main 
flavonoids present in Cy are luteolin derivatives (Figueirinha et al., 2008), and previous results 
evidenced luteolin as the best flavonoid candidate to provide anti-inflammatory relief in vivo 
(Comalada et al., 2006) as well as to inhibit the LPS-induced cytokine production through 
inhibition of the NF-B pathway (Chen et al., 2007). NF-B activation by an inflammatory 
stimulus, like LPS, is known to induce the expression of several inflammatory enzymes and 
mediators, such as iNOS, NO and cytokines (Vitiello et al., 2012). Here, it was evidenced that 
the anti-inflammatory effect of Cy extract is, at least in part, mediated by the NF-B pathway 
inhibition. Consistent with this mechanism, we previously described the decrease in NF-B-
dependent NO production by Cy and its PFs in murine macrophages (Francisco et al., 2011). 
The TNF- biosynthesis could be regulated not only by NF-B pathway but also by p38 MAPK 
(Xie et al., 2012) and JNK (Kang et al., 2010). Noteworthy, we have previously found that Cy 
inhibited p38 MAPK and JNK activation, indicating that both NF-B and MAPK could be 
involved in the inhibition of LPS-induced TNF- production by Cy extract. Supporting our data, 
Cy extract also posses p-coumaric derivatives that were previously described as inhibitors of 
NF-B-dependent iNOS and COX-2 expression (Yen et al., 2008). 
The inhibition of ubiquitin-proteasome system, with consequent blockade of NF-B 
pathway, reveals the anti-inflammatory potential of Cy extract. In fact, proteasome regulates 
protein degradation and homeostasis, having a key role in key inflammatory signaling pathways 
(Shen et al., 2006), cell cycle arrest and apoptosis. Therefore, ubiquitin-proteasome inhibition 
has been pointed not only as an anti-inflammatory target but also as an anti-neoplasic one 
(Gräwert and Groll, 2012). The available proteasome inhibitors, like bortezomib, are effective 
and selective, even though they possess toxic effects (Gräwert and Groll, 2012). Therefore, Cy 
extract could provide a potent but less cytotoxic proteasome inhibitor and, consequently, be a 
source of new anti-inflammatory and anti-neoplasic drugs. 
The phenolic acid- and tannin-rich fractions from Cy, demonstrated proteasome inhibitory 
activity, evidencing the presence of active compounds. Accordingly, tannins were reported to 
modulate proteins involved in ubiquitin-proteasome system (Li et al., 2008). Chemical 
characterization of Cy extract showed the chlorogenic acid as the main phenolic acid. Curiously, 
significant proteasome inhibitory properties, similar to that of Cymbopogon citratus extract, were 
evidenced when a standard of CGA was assayed for the concentration occurred in the PAF 
(17.5 g/mL). However, 1.115 mg/mL Cy, which only contains 12.37 g/mL of CGA, have a 
higher effect on proteasome activity than 17.5 g/mL CGA, suggesting that non-phenolic acid 
compounds were also involved. In fact, CGA was previously described as a proteasome 
inhibitor and anti-neoplasic agent (Cichocki et al., 2010), as well as a NF-B inhibitor (Shan et 
al., 2009), which reinforces our results. Accordingly, our data demonstrated that CGA maintains 
the phosphorylation levels of IB, which evidences an inhibition of both proteasome activity 
and NF-B activation. Since NF-B pathway controls the production of cytokines and NO, the 
anti-inflammatory properties of CGA were also investigated. The results evidenced an inhibition 
of LPS-induced NO production by CGA but at higher concentrations than those required for 
proteasome and NF-B inhibition, which indicates that CGA strongly contributed to inhibition of 
proteasome activity by Cy, but other compounds, namely tannins and flavonoids, have an 
higher contribution to the Cy anti-inflammatory properties. Therefore, CGA could be pointed as 
a bioactive compound of Cy and a good candidate for further research as inhibitor of ubiquitin-
proteasome system and therapeutical agent in diseases associated with proteasome 
deregulation, such as cancer. 
In conclusion, this work better elucidates the anti-inflammatory mechanism of Cymbopogon 
citratus via the inhibition of proteasome activity and, consequently, NF-B pathway and cytokine 
expression. Additionally, phenolic compounds, in particular chlorogenic acid, were pointed as 
bio-active compounds, revealing the importance of Cymbopogon citratus as source of new anti-
inflammatory natural drugs. 
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 R:TCTCAAGGAAGTCTGGAA 
CCL5 F:CAGTGAGCTGAGATTGTG 
 R:TTTGTTGTTGTTGTTGTGA 
F: Forward sequence; R: Reverse sequence. 
 
 
 
 
 
Figure legends 
 
Fig. 1. Chlorogenic acid of Cymbopogon citratus leaves. (A) Mass spectra. (B) Fragmentation 
pattern for hydroxycinnamic esters of quinic acid. (C) HPLC prole from phenolic acid-rich 
fraction, recorded at 320 nm, illustrating two main phenolic acids, namely chlorogenic acid 
(Rt=19.95 min) and p-coumaric acid (Rt=25.33 min), on conditions previously reported 
(Figueirinha et al., 2008). 
 
Fig. 2. Cymbopogon citratus (Cy) and its polyphenol-rich fractions inhibited LPS-induced TNF- 
(A) and CCL-5 (B) production as well as NF-B activation (C and D), in human macrophages. In 
the graphics, the results were expressed as fold changes relatively to LPS and each value 
represents the mean ± SEM from 3 independent experiments performed in duplicate 
(###p<0.001, when compared to control; *p<0.05 and ***p<0.001, when compared to LPS). The 
NF-B activation was analyzed by western blot using antibodies against phospho-IB (C) and 
total IB (D). Each blot shown is representative of 3 blots yielding similar results.  
 
Fig. 3. Cymbopogon citratus (Cy) and its polyphenol-rich fractions inhibited LPS-induced NF-B 
activation, in murine macrophages. Total cell extracts were analyzed by western blot using 
antibodies against phospho-IB (A) and total IB (B). The migration of NF-B p65 to the 
nucleus was analyzed using cytoplasmic (C) and nuclear (D) extracts. Each blot shown is 
representative of 3 blots yielding similar results. The NF-B transcriptional activity was 
measured using a NF-B-dependent luciferase reporter plasmid. The results were expressed as 
fold changes relatively to LPS and each value represents the mean ± SEM from 3 independent 
experiments (*p<0.05, when compared to LPS).  
 
Fig. 4. Cymbopogon citratus (Cy), phenolic acid-rich fraction (PAF) and chlorogenic acid (CGA) 
inhibited the chymotrypsin-like activity of murine macrophage proteasome. The results were 
expressed as fold changes relatively to LPS and each value represents the mean ± SEM from 3 
independent experiments (*p<0.05 and **p<0.01, when compared to LPS). 
 
Fig. 5. Chlorogenic acid (CGA) inhibited the LPS-induced nitrite production, in murine 
macrophages. The results were expressed as fold changes relatively to LPS and each value 
represents the mean ± SEM from 3 independent experiments (*p<0.05, when compared to 
LPS). 
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